Results 51 to 60 of about 379,801 (144)

Does ChAdOx1-S and BNT162b2 heterologous prime-boost vaccination trigger higher rates of vaccine-related adverse events?

, 2023
Background: There has been significant international interest in heterologous prime-boost COVID-19 vaccination. However, it is linked with different intensity and frequency of adverse events.
Amal Alfaifi, Al-Tawfiq, Jaffar A., Abdallah Alkattan, Hassanein, Mustafa, Elfadil Elkagam, Hani Jokhdar, Alfaifi, Amal, Alkattan, Abdallah, Mustafa Hassanein, Nagla Mahmoud, Mahmoud, Nagla, Jaffar A. Al-Tawfiq, Radwan, Nashwa, Haji, Alhan, Khaled Alabdulkareem, Elkagam, Elfadil, Nashwa Radwan, Alabdulkareem, Khaled, Jokhdar, Hani, Alhan Haji   +19 more
core   +1 more source

Immunogenicity and reactogenicity of a heterologous COVID-19 prime-boost vaccination compared with homologous vaccine regimens [PDF]

, 2021
Heterologous priming with the ChAdOx1-nCoV-19 vector-vaccine followed by boosting with an mRNA-vaccine is currently recommended in Germany, although data on immunogenicity and reactogenicity are not available.
Gärtner, Barbara C., Schneitler, Sophie, Schmidt, Tina, Sester, Urban, Klemis, Verena, Schub, David, Hielscher, Franziska, Marx, Stefanie, Becker, Sören, Sester, Martina, Abu-Omar, Amina, Mihm, Janine   +11 more
core   +1 more source

Anti-SARS-CoV-2 spike IgG following injection of the third dose vaccine: A systematic review with meta-analysis of heterologous versus homologous vaccination

Frontiers in Public Health, 2023
BackgroundThe mass vaccination is a key strategy to prevent and control the coronavirus disease 2019 (COVID-19) pandemic. Today, several different types of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed ...
Mohammad-Shafi Mojadadi, Mohammad-Shafi Mojadadi, Seyed Alireza Javadinia, Fahimeh Attarian, Elham Samami, Elham Samami, Mona Sobhani   +6 more
doaj   +1 more source

Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study

, 2022
Background: Heterologous prime-boost vaccination potentially augments the immune response against SARS-CoV-2 in liver transplant (LT) recipients. We investigated immunogenicity induced by different primary prime-boost vaccination protocols and the ...
Nipaporn Siripon, Kessarin Thanapirom, Hansasuta, Pokrath, Sirinporn Suksawatamnuay, Srisoonthorn, Nunthiya, Nonthasoot, Bunthoon, Panarat Thaimai, Siripon, Nipaporn, Pokrath Hansasuta, Piyawat Komolmit, Thanapirom, Kessarin, Ananchuensook, Prooksa, Supachaya Sriphoosanaphan, Prooksa Ananchuensook, Sriphoosanaphan, Supachaya, Suksawatamnuay, Sirinporn, Komolmit, Piyawat, Nunthiya Srisoonthorn, Thaimai, Panarat, Bunthoon Nonthasoot   +19 more
core   +1 more source

The Efficacy and Safety of Heterologous Immunization with Pfizer-BioNTech (Pfizer) to Individuals Who Have Completed A Primary Vaccination Schedule with Sinopharm (BBibp-CorV) [PDF]

, 2023
The aim of this study was to examine the effectiveness and potential adverse reactions when providing a different Pfizer-BioNTech booster shot to 235 volunteers who had previously received the BBIBP-CorV Sinopharm primary vaccination series.
Mohammed Rashid Ameen, Warveen L. Abdulkareem, Nawfal R. Hussein, Narin A. Rasheed   +3 more
core   +1 more source

Mortality in severe serious adverse events following heterologous and homologous prime-boost vaccination strategies for SARS-CoV-2: A retrospective cohort study.

PLoS ONE
The COVID-19 pandemic underscored the urgent need for widespread vaccination to achieve herd immunity and mitigate severe outcomes. To address vaccine supply constraints, heterologous prime-boost strategies were adopted in Korea and other countries ...
Min Cheol Song, Jongmok Ha, Suyeon Park, Hyunwook Kang, Taeeun Kyung, Namoh Kim, Dong Kyu Kim, Kihoon Bae, Kwang Jun Lee, Euiho Lee, Jin Myoung Seok, Jinyoung Youn   +11 more
doaj   +1 more source

Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany

Human Vaccines & Immunotherapeutics, 2021
Bacillus Calmette-Guérin (BCG) vaccine is known to have “bystander benefits” in protecting against heterologous infections; interim analysis of the “ACTIVATE” trial shows protection against respiratory infections in the elderly population.
Daniela Marín-Hernández, Douglas F. Nixon, Nathaniel Hupert   +2 more
doaj   +1 more source

Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study

Vaccines, 2022
Several studies have reported the benefits and safety of heterologous vaccination among different approved vaccines; however, there are no specific reports on the effects of vaccination with the Ad5-nCoV and other vaccines of the same or different ...
José Francisco Muñoz-Valle, Gabriela Athziri Sánchez-Zuno, Mónica Guadalupe Matuz-Flores, Cristian Oswaldo Hernández-Ramírez, Saúl Alberto Díaz-Pérez, Christian Johana Baños-Hernández, Francisco Javier Turrubiates-Hernández, Alejandra Natali Vega-Magaña, Jorge Hernández-Bello   +8 more
doaj   +1 more source

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity

Frontiers in Immunology, 2023
Currently available COVID-19 vaccines include inactivated virus, live attenuated virus, mRNA-based, viral vectored and adjuvanted protein-subunit-based vaccines.
Larissa Henze, Larissa Henze, Julian Braun, Julian Braun, Lil Meyer-Arndt, Lil Meyer-Arndt, Lil Meyer-Arndt, Lil Meyer-Arndt, Karsten Jürchott, Karsten Jürchott, Maike Schlotz, Janine Michel, Marica Grossegesse, Maike Mangold, Maike Mangold, Manuela Dingeldey, Manuela Dingeldey, Beate Kruse, Beate Kruse, Pavlo Holenya, Norbert Mages, Norbert Mages, Norbert Mages, Ulf Reimer, Maren Eckey, Karsten Schnatbaum, Holger Wenschuh, Bernd Timmermann, Florian Klein, Florian Klein, Florian Klein, Andreas Nitsche, Claudia Giesecke-Thiel, Lucie Loyal, Lucie Loyal, Andreas Thiel, Andreas Thiel   +36 more
doaj   +1 more source

Analyzing immune responses to varied mRNA and protein vaccine sequences

npj Vaccines, 2023
In response to the COVID-19 pandemic, different types of vaccines, such as inactive, live-attenuated, messenger RNA (mRNA), and protein subunit, have been developed against SARS-CoV-2. This has unintentionally created a unique scenario where heterologous
Hyeong-Jun Park, Yoo-Jin Bang, Sung Pil Kwon, Woori Kwak, Sang-In Park, Gahyun Roh, Seo-Hyeon Bae, Jae-Yong Kim, Hye Won Kwak, Yongkwan Kim, Soyeon Yoo, Daegeun Kim, Gyochang Keum, Eun-Kyoung Bang, So-Hee Hong, Jae-Hwan Nam   +15 more
doaj   +1 more source